Nordic Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.15 M
- Company Age 27 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.70 M
- Revenue Growth 50.65%
- Profit Growth 293.77%
- Ebitda 2361.59%
- Net Worth 7.41%
- Total Assets 30.85%
About Nordic Pharmaceuticals
Nordic Pharmaceuticals Limited (NPL) is a Public Limited Indian Non-Government Company incorporated in India on 16 September 1997 and has a history of 27 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.15 M.
The company currently has active open charges totaling ₹4.70 M.
Manoj Poddar, Manish Poddar, Banwari Poddar, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231DL1997PLC089698
- Company No.
089698
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Sep 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Nordic Pharmaceuticals Limited
Explore comprehensive data for Nordic Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Nordic Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Poddar  | Director | 16-Sep-1997 | Current |
| Manish Poddar | Director | 16-Sep-1997 | Current |
| Banwari Poddar | Director | 16-Sep-1997 | Current |
| Kusum Poddar | Director | 30-Mar-2015 | Current |
Financial Performance of Nordic Pharmaceuticals.
Nordic Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.65% increase. The company also saw a substantial improvement in profitability, with a 293.77% increase in profit. The company's net worth moved up by a moderate rise of 7.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nordic Pharmaceuticals?
In 2022, Nordic Pharmaceuticals had a promoter holding of 97.75% and a public holding of 2.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alaknanda Cruiseline Private LimitedManoj Poddar, Manish Poddar and 1 more are mutual person
Nordic Formulations Private LimitedManoj Poddar, Manish Poddar and 2 more are mutual person
- Kewat Hospitalities Private Limited
Manoj Poddar and Manish Poddar are mutual person
Charges (Loans)
Open Charges
₹4.70 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2014 | Bank Of India | ₹0.70 M | Open |
| 01 Feb 1999 | Bank Of India | ₹4.00 M | Open |
How Many Employees Work at Nordic Pharmaceuticals?
Unlock and access historical data on people associated with Nordic Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nordic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nordic Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nordic Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Nordic Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Nordic Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Bank Of India of Rs. 4.00 M registered on 01 Feb 1999 with Charge ID 90035047 was modified on 08 Mar 2019.
- Director Appointment
Kusum Poddar was appointed as a Director was appointed as a Director on 30 Mar 2015 & has been associated with this company since 10 years 1 month .
- Charges
A charge with Bank Of India amounted to Rs. 0.70 M with Charge ID 10510423 was registered on 26 Jun 2014.
- Charges
A charge with Bank Of India amounted to Rs. 4.00 M with Charge ID 90035047 was registered on 01 Feb 1999.
Recent News, Updates & Announcement
Nordic Group & Primex: A Powerful Pharma Partnership Saving Lives with Hospital Meds & Rare Disease Treatments #PharmaPowerCouple #BossMoves.Nordic Group and Primex team up to make sick people feel better. They make meds for hospitals and rare diseases. #PharmaPowerCouple #SavingLives #BossMoves.
- Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products.
/PRNewswire/ -- Cumberland Pharmaceuticals (NASDAQ: CPIX), a U.S. specialty pharmaceutical company has entered into an Agreement to acquire the exclusive U.S.....
Frequently asked questions
What is the Incorporation or founding date of Nordic Pharmaceuticals Limited?
Nordic Pharmaceuticals Limited was incorporated on 16 Sep 1997.
What is authorized share capital and paid-up capital of Nordic Pharmaceuticals Limited?
The authorized share capital of Nordic Pharmaceuticals Limited is ₹ 2.50 M and paid-up capital is ₹ 1.15 M.
Who are the current board members & directors of Nordic Pharmaceuticals Limited?
Currently 4 directors are associated with Nordic Pharmaceuticals Limited.
- Manoj Kumar Poddar
- Manish Poddar
- Banwari Lal Poddar
- Kusum Poddar
What is the registered address of Nordic Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Nordic Pharmaceuticals Limited is Nordeic House D 318 Avantika Sector I, Rohini India, New Delhi, 110085.
What is the corporate identification number (CIN) and company number of Nordic Pharmaceuticals Limited?
The corporate identification number (CIN) of Nordic Pharmaceuticals Limited is U24231DL1997PLC089698 and the company number is 089698 as per Ministry of Corporate Affairs (MCA).
What is the official website of Nordic Pharmaceuticals Limited?
The Official website of Nordic Pharmaceuticals Limited is https://www.nordicpharmagroup.com
What has been the recent revenue trend for Nordic Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Nordic Pharmaceuticals Limited has risen by 50.65%.
What change has been observed in the net worth of Nordic Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Nordic Pharmaceuticals Limited has experienced an upsurge of 7.41%.
What are the total open charges for Nordic Pharmaceuticals Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Nordic Pharmaceuticals Limited amount to ₹ 4.70 M.
When was the last Balance Sheet of Nordic Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Nordic Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
SP
Santosh PoddarDirector
Similar Companies Based on Pharmaceutical Retailers & Distributors
Wellness Forever Medicare Limited Mumbai, Maharashtra, India
Sun Pharma Distributors Limited Mumbai, Maharashtra, India
Novartis Healthcare Private Limited Mumbai, Maharashtra, India
Mylan Pharmaceuticals Private Limited Hyderabad, Telangana, India
Msd Pharmaceuticals Private Limited New Delhi, Delhi, India
Aster Dm Healthcare Limited Bangaluru, Karnataka, India
Reckitt Benckiser Healthcare India Private Limited Gurugram, Haryana, India
Apollo Hospitals Enterprise Limited Chennai, Tamil Nadu, India